· · · · · 

Buying Breast Milk Online Remains a Risky Proposition

Efforts to promote breast feeding as the best option for infants may have lead some parents to believe formula is not a good option and to turn to the Internet to find someone else’s milk, a practice the FDA says is unsafe.

Efforts to promote breastfeeding as the best option for infants may have led some parents to believe formula is not a good option and to turn to the Internet to find someone else’s milk, a practice the FDA says is unsafe.

· · · · · 

‘Robin Danielson Act’ Would Mandate Independent Testing on Tampon Safety

Almost no independent research has investigated the potential health impacts of long-term feminine hygiene product use. Studies have generally taken place through product manufacturers—who aren't required to release the results in full to the public.

Almost no independent research has investigated the potential health impacts of long-term feminine hygiene product use. Studies have generally taken place through product manufacturers—who aren’t required to release the results in full to the public.

· · · · · 

Native American Women Still Don’t Have Access to OTC Emergency Contraception

It's been two years since the FDA made certain types of emergency contraception available without a prescription to women of all ages, but Indian Health Service has yet to update its policy.

It’s been two years since the FDA made certain types of emergency contraception available without a prescription to women of all ages, but Indian Health Service has yet to update its policy.

· · · · · 

FDA Approves New IUD Designed To Be More Affordable

Liletta, an IUD just approved by the FDA, is being marketed in the United States through a unique partnership between manufacturers who hope to bring the device to more people at a lower cost. However, it is still unclear whether those savings will be felt by all women.

Liletta, an IUD just approved by the FDA, is being marketed in the United States through a unique partnership between manufacturers who hope to bring the device to more people at a lower cost. However, it is still unclear whether those savings will be felt by all women.

· · · · · 

Legal Wrap: Another Grand Jury Fails to Indict, Supreme Court Ponders Online Harassment

A New York grand jury failed to indict the officers involved in Eric Garner's death, while the Roberts Court heard arguments in two big cases for equality advocates.

A New York grand jury failed to indict the officers involved in Eric Garner’s death, while the Roberts Court heard arguments in two big cases for equality advocates.

· · · · · 

This Week in Sex: Scientists Grow Penises, One Couple Regrets Sex on the Beach

This week, six lab-grown penises are almost ready for implantation, and an Italian couple apparently became stuck together after a tryst at the beach went awry.

This week, six lab-grown penises are almost ready for implantation, and an Italian couple apparently became stuck together after a tryst at the beach went awry.

· · · · · 

The FDA Needs an Action Plan for More Inclusive Clinical Trials

If not enough women and people of color are included in clinical trials, it is not possible to determine how they’re affected by the new drug or device. And without this information women, particularly women of color, can’t make informed decisions about the medical products available.

If not enough women and people of color are included in clinical trials, it is not possible to determine how they’re affected by the new drug or device. And without this information women, particularly women of color, can’t make informed decisions about the medical products available.

· · · · · 

Buyer Beware: Can We Trust Cheap Plan B One-Step on Amazon.com?

Recently, social media lit up with the news that Amazon.com vendors are selling Plan B One-Step emergency contraception for as low as $16.90 plus shipping. We have to ask: How is it that possible?

Recently, social media lit up with the news that Amazon.com vendors are selling Plan B One-Step emergency contraception for as low as $16.90 plus shipping. We have to ask: How is that possible?

· · · · · 

Cost, Inequality, and Misinformation: Why Generic Emergency Contraception Is Still Inaccessible for Many

There are still barriers to EC access, especially for women and teens of color who disproportionately live in poor and segregated neighborhoods.

Though the FDA decision to permit generic EC pill manufacturers to sell their products over the counter represents a gain for those with the most access to resources, ultimately the decision reflects pharmaceutical manufacturing companies’ interests, rather than the lives of those most adversely affected by lack of access to EC.

· · · · · 

FDA Panel Considers Replacing the Pap Test

Current recommendations suggest Pap tests be used as primary screening tools for cervical cancer, but some experts would like to see newer DNA testing used more often.

Current recommendations suggest Pap tests be used as primary screening tools for cervical cancer, but some experts would like to see newer DNA testing used more often.

· · · · ·